Psilocybin-assisted psychotherapy for cancer-related anxiety and depression - Dan Yaniv; Lois M. Ramondetta; Lorenzo Cohen; Moran Amit (International Journal of Gynecological Cancer, 2023)

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication - Guy M. Goodwin; Megan Croal; David Feifel; John R. Kelly; Lindsey Marwood; Sunil Mistry; Veronica O’Keane; Stéphanie Knatz Peck; Hollie Simmons; Claudia Sisa; S. C. Stansfield; Joyce Tsai; et al. (Neuropsychopharmacology, 2023)

Must Psilocybin Always “Assist Psychotherapy”? - Guy M. Goodwin; Ekaterina Malievskaia; Gregory A. Fonzo; Charles B. Nemeroff (American Journal of Psychiatry, 2023)

Australia’s approval of MDMA and psilocybin for PTSD and depression is premature, say critics - Bianca Nogrady (BMJ, 2023)

Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice - Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maede K; González-Maeso J; Kitagaki S; et al. (Research Square, 2023)

Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin - Tetem J; Fischmann T; Möller TJ. (PsyArXiv, 2023)

Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD) - Cybin Therapeutics Inc. (ClinicalTrials.gov, 2023)

Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin (PsyArXiv, 2023)

Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review. - Hovmand OR; Poulsen ED; Arnfred S; Storebø OJ. (2023)

Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effects - McCulloch DE; Olsen AS; Ozenne B; Stenbaek DS; Armand S; Madsen MK; Knudsen GM; Fisher PM. (medRxiv, 2023)

Psilocybin's effects on cognition and creativity: A scoping review. - Bonnieux JN; VanderZwaag B; Premji Z; Garcia-Romeu A; Garcia-Barrera MA. (2023)

Psychedelic drug psilocybin shows promise treating anorexia in early trials - Grace Wade (The New Scientist, 2023)

Serotonin 5-HT2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents. - McIntyre RS. (2023)

Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents. - McIntyre RS. (2023)

Assessing potential of psilocybin for depressive disorders. - Kozak Z; Johnson MW; Aaronson ST. (2023)

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial - Muhammad Ishrat Husain; Daniel M. Blumberger; David Castle; Nicole Ledwos; Elise Fellows; Brett D. M. Jones; Abigail Ortiz; Stefan Kloiber; Wei Wang; Joshua D. Rosenblat; Benoit H. Mulsant (BJPsych Open, 2023)

Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study - Gwyther M; Aspell JE. (PsyArXiv, 2023)

Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study (PsyArXiv, 2023)

Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives. - Jachimowski A; Kucia K. (2023)

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first - Rich Haridy (Nature, 2023)

Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms - Patrick D. Skosnik; Jordan Sloshower; Hamideh Safi-Aghdam; Surbhi Pathania; Shariful A. Syed; Brian Pittman; Deepak Cyril D’Souza (Journal of Psychopharmacology, 2023)

Clinical specificity profile for novel rapid acting antidepressant drugs. - Scala M; Fanelli G; De Ronchi D; Serretti A; Fabbri C. (2023)

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder - Halucenex Life Sciences Inc. (ClinicalTrials.gov, 2023)

Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review. - Lee HJ; Tsang VW; Chai BS; Lin MC; Howard A; Uy C; Elefante JO. (2023)

Psilocybin: The most effective moral bio-enhancer? - Vojin Rakić (Bioethics, 2023)

Psilocybin decelerates cellular senescence - Hecker L; kato k; Kleinhenz JMK; Shin Y; Papageorgiou J; Zarrabi A. (Research Square, 2023)

Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants. - Chen T; Cheng L; Ma J; Yuan J; Pi C; Xiong L; Chen J; Liu H; Tang J; Zhong Y; Zhang X; Liu Z; et al. (2023)

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats - Filip Tylš; Čestmír Vejmola; Vlastimil Koudelka; Václava Piorecká; L. Kadeřábek; Marcel Bochin; Tomáš Novák; Martin Kuchař; Zdeňka Bendová; Martin Brunovský; Jiřı́ Horáček; Tomáš Pálení ček (Frontiers in Neuroscience, 2023)

Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data - Bheatrix Bienemann; Amanda Rocha Barbosa; Lucas Villar Magalhães da Cruz; Marco Multedo; Daniel C. Mograbi (Journal of Psychoactive Drugs, 2023)

Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms. - Calder A; Mock S; Friedli N; Pasi P; Hasler G. (2023)

“Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli” - Jessica E. Flower; William J. Gibbons; Alexandra M. Adams; Xin Wang; Caroline N. Broude; J. Andrew Jones (Biotechnology and Bioengineering, 2023)

Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis - M. Nikolič; Vojtěch Viktorin; Peter Zach; Filip Tylš; Daniela Dudysová; Karolína Janků; Jana Kopřivová; Martin Kuchař; Martin Brunovský; Jiřı́ Horáček; Tomáš Páleníček (European Neuropsychopharmacology, 2023)

A case-study evaluation of the “Copenhagen Music Program” for psilocybin-assisted therapy - Gina Ratkovic; Mike Sosteric; Tristan Sosteric (Frontiers in Psychology, 2023)

HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer - Benjamin R. Lewis; Eric L. Garland; Kevin Byrne; Tyler Durns; John Hendrick; Anna C. Beck; Paul Thielking (Journal of Pain and Symptom Management, 2023)

The treatment of abandonment anxiety with MDMA and LSD - Turkia M. (PsyArXiv, 2023)

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study - Nayak SM; White S; Hilbert S; Lowe MX; Jackson H; Griffiths RR; Garcia-Romeu A; Yaden DB. (PsyArXiv, 2023)

Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study - Turkia M. (PsyArXiv, 2023)

The treatment of abandonment anxiety with MDMA and LSD (PsyArXiv, 2023)

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study - Nayak SM; White SH; Hilbert S; Lowe MX; Jackson H; Griffiths RR; Garcia-Romeu A; Yaden DB. (PsyArXiv, 2023)

Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study (PsyArXiv, 2023)

Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study (PsyArXiv, 2023)

No trip needed for psychedelics to lift mood? - O'Grady C. (2023)

Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use - Natalie Gukasyan; Roland R. Griffiths; David B. Yaden; Denis Antoine; Sandeep M. Nayak (Journal of Psychopharmacology, 2023)

Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes - Nkadimeng SM; Steinmann CM; Eloff JN. (Preprints.org, 2023)

Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence. - Koning E; Brietzke E. (2023)

Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis. - Gabrielle Agin-Liebes; Elizabeth M. Nielson; Michael A. Zingman; Katherine Kim; Alexandra Haas; Lindsey T. Owens; Ursula Rogers; Michael P. Bogenschutz (Psychology of Addictive Behaviors, 2023)

The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness - Schmidt TT; Costines C; Tagliazucchi E; Millière R; Garrido JM; Cuiule JI. (PsyArXiv, 2023)

Is Microdosing a Placebo? - Polito V; Liknaitzky P. (PsyArXiv, 2023)

The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness (PsyArXiv, 2023)

Is Microdosing a Placebo? (PsyArXiv, 2023)

Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression - Wall MB; Demetriou L; Giribaldi B; Roseman L; Ertl N; Erritzoe D; Nutt DJ; Carhart-Harris RL. (medRxiv, 2023)

Psilocybin therapy: A novel approach to treating depression - Tooba Noor; Areej Shakil; Aimen Waqar Khan; Syeda Mahrukh Fatima Zaidi; Hussain Sohail Rangwala; Burhanuddin Sohail Rangwala (International Journal of Surgery Global Health, 2023)

Psilocybin (Magic Mushrooms) - N. Jiten Singh (GFNPSS-International Journal of Multidisciplinary Research, 2023)

Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories - Federica Benvenuti; Daniele Colombo; Laura Soverchia; Nazzareno Cannella; Esi Domi; Roberto Ciccocioppo (Psychopharmacology, 2023)

Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model - Paul McCrone; Henry Fisher; Clare Knight; Rebecca Harding; Anne Katrin Schlag; David Nutt; Joanna C. Neill (Psychological Medicine, 2023)

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression - Brandon Weiss; Induni Ginige; Lu Shannon; Bruna Giribaldi; Ashleigh Murphy-Beiner; Roberta Murphy; Michelle Baker-Jones; Jonny Martell; David Nutt; Robin Carhart-Harris; David Erritzøe (Psychological Medicine, 2023)

Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD). - Manish Agrawal; Sarah Shnayder; Heather Honstein; Ezekiel Emanuel; Paul Thambi (Journal of Clinical Oncology, 2023)

ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study Design - Basant Pradhan; Ankit Rana; Edward Goldschmidt; Anthony L. Rostain (Neuromodulation Technology at the Neural Interface, 2023)

Global species diversity and distribution of the psychedelic fungal genus Panaeolus - Strauss D; Ghosh S; Murray Z; Gryzenhout M. (2023)

Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review - Halman A; Kong G; Sarris J; Perkins D. (medRxiv, 2023)

The Perilous Policy of Oregon's Psilocybin Services. - Holoyda B. (2023)

Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress. - Gold ND; Podrebarac SK; White LA; Marini C; Simon NM; Mittelman MS; Ross S; Bogenschutz MP; Petridis PD (Psychedelic medicine (New Rochelle, N.Y.), 2023)

Supplemental Material for Reports of Self-Compassion and Affect Regulation in Psilocybin-Assisted Therapy for Alcohol Use Disorder: An Interpretive Phenomenological Analysis (Psychology of Addictive Behaviors, 2023)

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics. - Evens R; Schmidt ME; Majić T; Schmidt TT. (2023)

Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression". - Brown O. (2023)

Evidence versus expectancy: the development of psilocybin therapy - James Rucker (BJPsych Bulletin, 2023)

Psychedelics: Threshold of a Therapeutic Revolution. - Heal DJ; Smith SL; Belouin SJ; Henningfield JE. (2023)

Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism - Whelan TP; Daly E; Puts NA; Malievskaia E; Murphy DG; McAlonan GM. (medRxiv, 2023)

Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans - Combat Stress (ClinicalTrials.gov, 2023)

New Pharmacologic Approaches to the Treatment of Bipolar Depression. - Keramatian K; Chakrabarty T; DuBow A; Saraf G; Yatham LN. (2023)

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants - Laura Ley; Friederike Holze; Denis Arikci; A. Becker; Isabelle Straumann; Aaron Klaiber; Fabio Coviello; Sophie Dierbach; Jan Thomann; Urs Duthaler; Dino Luethi; Nimmy Varghese; et al. (Neuropsychopharmacology, 2023)

Neurobiological Correlates of Psilocybin Response in Depression. - Qasim S; Zaheer Z; Jawad MY; Shad MU. (2023)

Acute psilocybin increased cortical activities in rats - Junhong Liu; Yuanyuan Wang; Ke Xia; Jinfeng Wu; Danhao Zheng; Aoling Cai; Haitao Yan; Ruibin Su (Frontiers in Neuroscience, 2023)

Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers - University of Wisconsin; Madison (ClinicalTrials.gov, 2023)

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review. - Fonseka LN; Woo BK. (2023)

[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application]. - Lasch A; Schweikert T; Dora E; Kolb T; Schurig HL; Walther A. (2023)

Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders - Raithatha SA; Hagel JM; Matinkhoo K; Yu L; Press D; Cook SG; Sharma G; D D; Jensen G; Lee JB; Cai C; Gallant J; et al. (bioRxiv, 2023)

The evolution and ecology of psilocybin in nature. - Meyer M; Slot J. (2023)

Global species diversity and distribution of the psychedelic fungal genus Panaeolus. - Strauss D; Ghosh S; Murray Z; Gryzenhout M. (2023)

A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin - University of Wisconsin; Madison (ClinicalTrials.gov, 2023)

Exposure therapy under psilocybin for general anxiety disorder and claustrophobia - THORENS G; PENZENSTADLER l; FURTADO LCDC; SERAGNOLI F; ROTHEN S; MABILAIS C; ZULLINO D. (Research Square, 2023)

Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience - Singleton SP; Timmermann C; Luppi AI; Eckernäs E; Roseman L; Carhart-Harris RL; Kuceyeski A. (bioRxiv, 2023)

Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders. - Kargbo RB. (2023)

The down-scheduling of MDMA and psilocybin(e): Too fast and too soon. - Kisely S. (2023)

Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis - Suhwoo Bae; Michael Vaysblat; Edward Jong Bae; Ilja Dejanovic; Matthew Pierce (Cureus, 2023)

Effects of Psilocybin in Anorexia Nervosa - Johns Hopkins University (ClinicalTrials.gov, 2023)

Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434. - Gaddis A; Lidstone DE; Nebel MB; Griffiths RR; Mostofsky SH; Mejia AF; Barrett FS. (2023)

Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder? - Rossell SL; Meikle SE; Williams ML; Castle DJ. (2023)

How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change - Richard J. Zeifman; Anne Catherine Wagner; Candice M. Monson; Robin Carhart-Harris (Journal of Affective Disorders, 2023)

Using Psilocybin Therapy for treating end of life distress trial - Margaret Ross; Justin Dwyer (The Ballarat naturalist., 2023)

Unblinding and demand characteristics in the treatment of depression. - Goodwin GM; Croal M; Marwood L; Malievskaia E (Journal of affective disorders, 2023)

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD - Alan K. Davis; Adam W. Levin; Paul Nagib; Stacey B. Armstrong; Rafael Lancelotta (BMJ Open, 2023)

Psilocybin-Based Breakthroughs in Natural Medicine - Dunn Harmony; Freeman Judy; Michael John Dochniak (Case Reports and Reviews, 2023)

Psilocybin-based mushrooms and usage - Dunn Harmony; Freeman Judy; D Michael (Case Reports and Reviews, 2023)

Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’ - McAlpine R; Blackburne G; Kamboj S. (PsyArXiv, 2023)

Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’ (PsyArXiv, 2023)

A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history - Eric N. Kramer; Kalyn Reddy; Bryan Shapiro (Psychiatry Research Case Reports, 2023)

Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial - Terence H. W. Ching; Rachael Grazioplene; Calvin Bohner; Stephen A. Kichuk; Giuliana DePalmer; Elizabeth J. D’Amico; Jeffrey Eilbott; Anastasia Jankovsky; Michelle Burke; Jamila Hokanson; Brad Martins; Chelsea Witherow; et al. (Frontiers in Psychiatry, 2023)

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression - Brandon Weiss; David Erritzøe; Bruna Giribaldi; David Nutt; Robin Carhart-Harris (Journal of Psychopharmacology, 2023)

Psychedelic Sensationalism: An Analysis of the Schedule Classification of Psilocybin - Elisabeth Jean Wood (Vanderbilt Undergraduate Research Journal, 2023)

The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression - COMPASS Pathways (ClinicalTrials.gov, 2023)

A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy - Bennett JN; Blough MD; Mitchell I; Galloway L; Bains R. (medRxiv, 2023)

High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin - Braun D; Rosenberg A; Haruvi R; Malamud D; Barbara R; Kawashima T. (bioRxiv, 2023)

Psilocybin in Palliative Care: An Update. - Whinkin E; Opalka M; Watters C; Jaffe A; Aggarwal S. (2023)

Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder - Manish Agrawal; Ezekiel Emanuel; Brian D. Richards; William A. Richards; Kim Roddy; Paul Thambi (JAMA Oncology, 2023)

Predictors of Medical Students’ Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice - Karina Wang; Yiqun Sun; Brenda Nava; Luke Sampiere; Robin J. Jacobs (Cureus, 2023)

118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment? - Aron Amaev; Jianmeng Song; Yasaman Kambari; Fumihiko Ueno; Edgardo Torres-Carmona; Ali Abdolizadeh; Teruki Koizumi; Vincenzo De Luca; Bruce G. Pollock; Alastair J. Flint; Muhammad Ishrat Husain; Ariel Graff-Guerrero; et al. (Biological Psychiatry, 2023)

347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder - Xi Zhu; David J. Hellerstein; Jamie D. Feusner; Michael G. Wheaton; Gloria Gómez; Franklin R. Schneier (Biological Psychiatry, 2023)

96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression - Scott Aaronson; Tammy Miller; Samuel Rudow; MacKenzie Forbes; Audrey Shoultz; Trisha Suppes (Biological Psychiatry, 2023)

The Theoretical Description for Psilocin Electrochemical Determination over Cobalt Oxyhydroxide - Volodymyr Tkach; Kucher Mykhailo; Kushnir Marta; Ivanushko Yana; Akınay Yüksel; Karakoyun Necdet; Yagodynets Petro; Kormosh Zholt (Orbital: The Electronic Journal of Chemistry, 2023)

Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment - Jianmeng Song; Yasaman Kambari; Aron Amaev; Fumihiko Ueno; Edgardo Torres Carmona; Vincenzo De Luca; Bruce G. Pollock; Alastair J. Flint; Muhammad Ishrat Husain; Ariel Graff-Guerrero; Philip Gerretsen (Medical Hypotheses, 2023)

Use of Selective Alternative Therapies for Treatment of OCD. - Khan I; Jaura TA; Tukruna A; Arif A; Tebha SS; Nasir S; Mukherjee D; Masroor N; Yosufi A. (2023)

The molecular basis of the antidepressant action of the magic mushroom extract, psilocin - Ali Asghar Hakami Zanjani; Teresa Quynh Tram Nguyen; Luise Jacobsen; Himanshu Khandelia (Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2023)

Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs. - Zia FZ; Baumann MH; Belouin SJ; Dworkin RH; Ghauri MH; Hendricks PS; Henningfield JE; Lanier RK; Ross S; Berger A. (2023)

Psilocybin zeigt Wirkung bei Depression. - Julia Mertens L. (2023)

Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. - Simonsson O; Hendricks PS; Chambers R; Osika W; Goldberg SB (Journal of affective disorders, 2023)

Liminal spaces, seasonal faces: Challenging drug market assumptions via an exploration of naturally occurring magic mushroom markets in rural Kent. - Simpson GHR; Chatwin C; van Hellemont E (The International journal on drug policy, 2023)

Systematic Review of Interventions for Demoralization in Patients With Cancer. - Wang Y; Sun H; Ji Q; Wei J; Zhu P. (2023)

Classic psychedelic use and current meditation practice. - Simonsson C; Chambers R; Hendricks PS; Goldberg SB; Osika W; Schlosser M; Ryde A; Christersson E; Simonsson O (Mindfulness, 2023)

Psychotherapy with Psilocybin for Depression: Systematic Review. - Dawood Hristova JJ; Pérez-Jover V. (2023)

The need for establishing best practices and gold standards in psychedelic medicine. - Feduccia A; Agin-Liebes G; Price CM; Grinsell N; Paradise S; Rabin DM. (2023)

Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity - Yingjie Du; Yunfeng Li; Xiangting Zhao; Yishan Yao; Bin Wang; Liming Zhang; Guyan Wang (Chinese Medical Journal, 2023)

Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness - University Hospital; Basel; Switzerland (ClinicalTrials.gov, 2023)

[Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics]. - Ibi D. (2023)

Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder - Franklin R. Schneier; Jamie D. Feusner; Michael G. Wheaton; Gloria J. Gomez; Giselle Cornejo; Akansha M. Naraindas; David J. Hellerstein (Journal of Psychiatric Research, 2023)

Role of Psychedelics in Treatment-Resistant Depression. - Kamal S; Jha MK; Radhakrishnan R. (2023)

In silico characterization of the psilocybin biosynthesis pathway - William Irvine; Marshall Tyler; Rupika Delgoda (Computational Biology and Chemistry, 2023)

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism. - Domanegg K; Sommer WH; Meinhardt MW. (2023)

Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects. - Rosenblat JD; Leon-Carlyle M; Ali S; Husain MI; McIntyre RS. (2023)

The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience - Tolle HM; Farah JC; Mallaroni P; Mason NL; Ramaekers JG; Amico E. (bioRxiv, 2023)

Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study - Optimi Health Corporation (ClinicalTrials.gov, 2023)

Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial - Jordan Sloshower; Patrick D. Skosnik; Hamideh Safi-Aghdam; Surbhi Pathania; Shariful A. Syed; Brian Pittman; Deepak Cyril D’Souza (Journal of Psychopharmacology, 2023)

Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review. - Sharma R; Batchelor R; Sin J. (2023)

Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD - Ching THW; Grazioplene R; Pittenger C; Kelmendi B. (PsyArXiv, 2023)

Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD (PsyArXiv, 2023)

Trends in drug use among nightclub and festival attendees in New York City, 2017-2022. - Palamar JJ; Le A; Cleland CM; Keyes KM. (2023)

Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health. - Ryan RS; Copello A; Fox AP (BMC psychiatry, 2023)

The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice - Timur Zanikov; Marta Gerasymchuk; Esmaeel Ghasemi Gojani; Gregory Ian Robinson; Shima Asghari; Alyssa Groves; Lucie Haselhorst; Sanjana Nandakumar; Cora Stahl; Mackenzie Cameron; Dongping Li; Rocio Rodriguez-Juarez; et al. (Molecules, 2023)

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. - Brett J; Knock E; Korthuis PT; Liknaitzky P; Murnane KS; Nicholas CR; Patterson JC; Stauffer CS. (2023)

Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder - New York State Psychiatric Institute (ClinicalTrials.gov, 2023)

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders. - Wulff AB; Nichols CD; Thompson SM. (2023)

Patternizing Psilocybin in Logic Space - Parker Emmerson (Zenodo (CERN European Organization for Nuclear Research), 2023)

Understanding psychedelic 'mystical experience'-A case example - Turkia M. (PsyArXiv, 2023)

Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study - Turkia M. (PsyArXiv, 2023)

Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study - Turkia M. (PsyArXiv, 2023)

Understanding psychedelic 'mystical experience'-A case example (PsyArXiv, 2023)

Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study (PsyArXiv, 2023)

Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study (PsyArXiv, 2023)

Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles. - Kalkman HO (Biomedicines, 2023)

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020 - Emma I Kopra; Jason Ferris; Adam Winstock; Kim P. C. Kuypers; Allan H. Young; James Rucker (Journal of Psychopharmacology, 2023)

Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review. - Lazur J; Hnatyk K; Kała K; Sułkowska-Ziaja K; Muszyńska B. (2023)

Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded. - Otterman LS (Journal of bioethical inquiry, 2023)

Interaction of psychedelic tryptamine derivatives with a lipid bilayer. - Zohairi F; Khandelia H; Hakami Zanjani AA (Chemistry and physics of lipids, 2023)

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape. - Jha MK; Mathew SJ. (2023)

Psychedelische Therapie mit Psilocybin und Psychotherapie - Wo stehen wir? - Anne Karow (PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie, 2023)

The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study - Daniel A Kinderlehrer (International Medical Case Reports Journal, 2023)

A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression - Meghan Hibicke; Hannah M. Kramer; Charles D. Nichols (Psychedelic Medicine, 2023)

Default Mode Network Modulation by Psychedelics: A Systematic Review. - Gattuso JJ; Perkins D; Ruffell S; Lawrence AJ; Hoyer D; Jacobson LH; Timmermann C; Castle D; Rossell SL; Downey LA; Pagni BA; Galvão-Coelho NL; et al. (2023)

National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities. - Xi D; Berger A; Shurtleff D; Zia FZ; Belouin S. (2023)

Effect of psilocybin on decision-making and motivation in the healthy rat. - 飯倉 洋治; 馬場 實; 三河 春樹; 西間 三馨; 前田 和一; 赤坂 徹; 正木 拓朗; 有田 昌彦 (PubMed, 2023)

UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice - Rijsketic DR; Casey AB; Barbosa DA; Zhang X; Hietamies TM; Ramirez-Ovalle G; Pomrenze M; Halpern CH; Williams LM; Malenka RC; Heifets BD. (bioRxiv, 2023)

Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition - Mallaroni P; Mason NL; Reckweg JT; Paci R; Ritscher S; Toennes SW; Theunissen EL; Kuypers KP; Ramaekers JG. (bioRxiv, 2023)

Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis. - Crowe M; Manuel J; Carlyle D; Lacey C. (2023)

The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy - Jeffery Heilman (Journal of Scientific Exploration, 2023)

Therapeutic effect of psilocybin in addiction: A systematic review. - van der Meer PB; Fuentes JJ; Kaptein AA; Schoones JW; de Waal MM; Goudriaan AE; Kramers K; Schellekens A; Somers M; Bossong MG; Batalla A. (2023)

Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines. - Henríquez-Hernández LA; Rojas-Hernández J; Quintana-Hernández DJ; Borkel LF. (2023)

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life - Guy M. Goodwin; Scott T. Aaronson; Oscar Alvarez; Merve Atli; James Bennett; Megan Croal; Charles DeBattista; Boadie W. Dunlop; David Feifel; David J. Hellerstein; Muhammad Ishrat Husain; John R. Kelly; et al. (Journal of Affective Disorders, 2023)

Wirkt Psilocybin nachhaltig antidepressiv? - Lea J. Mertens (InFo Neurologie + Psychiatrie, 2023)

More on psilocybin - Aryan Sarparast (Current Psychiatry, 2023)

Psilocybin therapy for depression. A good trip? - Rucker JJ. (2023)

Psilocybin for Treatment-Resistant Depression. - Østergaard SD; Hieronymus F. (2023)

Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs. - Oster E; Čudina N; Pavasović H; Prevendar Crnić A; Božić F; Fadel C; Giorgi M. (2023)

SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression - Washington University School of Medicine (ClinicalTrials.gov, 2023)

Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'. - von Rotz R; Schindowski EM; Jungwirth J; Schuldt A; Rieser NM; Zahoranszky K; Seifritz E; Nowak A; Nowak P; Jäncke L; Preller KH; Vollenweider FX. (2023)

Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation - Nadav Liam Modlin; Tammy M. Miller; James Rucker; Namik Kirlić; Molly Lennard-Jones; Danielle Schlosser; Scott T. Aaronson (Journal of Affective Disorders, 2023)

Psychedelics: Science sabotaged by Social Media. - Sellers EM; Romach MK. (2023)

Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective. - Stokłosa I; Więckiewicz G; Stokłosa M; Piegza M; Pudlo R; Gorczyca P. (2023)

Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder - Dragana Marković; Eleonora Čapelja (AIDASCO Reviews, 2023)

Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder - Keith Heinzerling (ClinicalTrials.gov, 2023)

Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands - Anna Lutkajtis; Jules Evans (Journal of Psychedelic Studies, 2023)

Utility of preclinical models in the study of psilocybin - A comprehensive review. - Pedicini M; Cordner ZA. (2023)

Psychedelics for Patients With Cancer: A Comprehensive Literature Review. - White CM; Weisman N; Dalo J. (2023)

Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions. - Capaldi JM; Shabanian J; Finster LB; Asher A; Wertheimer JC; Zebrack BJ; Shirazipour CH. (2023)

Are psychedelics the answer to chronic pain: A review of current literature. - Kooijman NI; Willegers T; Reuser A; Mulleners WM; Kramers C; Vissers KCP; van der Wal SEI. (2023)

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology. - Mastinu A; Anyanwu M; Carone M; Abate G; Bonini SA; Peron G; Tirelli E; Pucci M; Ribaudo G; Oselladore E; Premoli M; Gianoncelli A; et al. (2023)

Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling - Jing Wang; Min Liang; Qing Shang; Hongyan Qian; Ran An; Hua Liu; Gaojie Shao; Tao Li; Xinshe Liu (CNS Neuroscience & Therapeutics, 2023)

Acute psilocybin enhances cognitive flexibility in rats - Pacheco AT; Olson RJ; Garza G; Moghaddam B. (bioRxiv, 2023)

Healing at death’s door: one patient’s mystical experience with psilocybin - Houman Farzin (International Journal of Whole Person Care, 2023)

When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s. - Martinovic J. (História Ciências Saúde-Manguinhos, 2023)

An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations. - Baker KM; Ulrich CM; Meghani SH. (2023)

Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst - Andersen S. (PsyArXiv, 2023)

Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst (PsyArXiv, 2023)

Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice - Kenneth Alper; Janelle Cange; Ria Sah; Deanna Schreiber-Gregory; Henry Sershen; K. Yaragudri Vinod (Frontiers in Pharmacology, 2023)

Cognitive liberty and the constitutionality of criminalising psilocybin mushrooms in South Africa - Sebastian William Foster (South African Journal on Human Rights, 2023)

Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights - Poonam Bhadoria; V. Ramanathan (ChemistrySelect, 2023)

Psilocin esters - An investigation of synthetic feasibility, chemical, and metabolic stability - Eklund; Julia (Zenodo (CERN European Organization for Nuclear Research), 2022)

In Search of: A Federal Safe Harbor for State Legalization of Psilocybin - Tucker; Kathryn L.; Martinez; Holly; Morris; Ebony (2022)

Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling - Klaus Richter Larsen; Ulrich Lindberg; Brice Ozenne; Drummond E-Wen McCulloch; Sophia Armand; M. Madsen; Annette Johansen; Dea Siggaard Stenbæk; Gitte M. Knudsen; Patrick M. Fisher (Neuroscience Applied, 2022)

Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model - Ines Erkizia-Santamaría; Guadalupe Rivero; Igor Horrillo; J. Javier Meana; Jorge E. Ortega (Neuroscience Applied, 2022)